These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 25818408)
21. Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome. Vylet'al P; Kublová M; Kalbácová M; Hodanová K; Baresová V; Stibůrková B; Sikora J; Hůlková H; Zivný J; Majewski J; Simmonds A; Fryns JP; Venkat-Raman G; Elleder M; Kmoch S Kidney Int; 2006 Sep; 70(6):1155-69. PubMed ID: 16883323 [TBL] [Abstract][Full Text] [Related]
22. Identification of a novel UMOD mutation (c.163G>A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease. Lopes LB; Abreu CC; Souza CF; Guimaraes LER; Silva AA; Aguiar-Alves F; Kidd KO; Kmoch S; Bleyer AJ; Almeida JR Braz J Med Biol Res; 2018 Mar; 51(3):e6560. PubMed ID: 29513881 [TBL] [Abstract][Full Text] [Related]
23. Significance of kidney biopsy in autosomal dominant tubulointerstitial kidney disease-UMOD: is kidney biopsy truly nonspecific? Onoe T; Hara S; Yamada K; Zoshima T; Mizushima I; Ito K; Mori T; Daimon S; Muramoto H; Shimizu M; Iguchi A; Kuma A; Ubara Y; Mitobe M; Tsuruta H; Kishimoto N; Imura J; Konoshita T; Kawano M BMC Nephrol; 2021 Jan; 22(1):1. PubMed ID: 33397327 [TBL] [Abstract][Full Text] [Related]
24. Medullary sponge kidney with IgA nephropathy: a case report and literature review. Zeng C; Jin Y; Wang Y; Zhu D; Zhang Z; Wang X BMC Nephrol; 2024 May; 25(1):154. PubMed ID: 38702597 [TBL] [Abstract][Full Text] [Related]
25. [Hyperuricemia due to renal failure, autosomal dominant polycystic kidney disease and lead nephropathy]. Hosoya T Nihon Rinsho; 2003 Jan; 61 Suppl 1():294-8. PubMed ID: 12629734 [No Abstract] [Full Text] [Related]
26. IgA nephropathy in cystic fibrosis. Stirati G; Antonelli M; Fofi C; Fierimonte S; Pecci G J Nephrol; 1999; 12(1):30-1. PubMed ID: 10203000 [TBL] [Abstract][Full Text] [Related]
27. IgA nephropathy in teaching hospitals of Dhaka. Sharmin F; Khan BR; Rahman M; Rashid HU; Islam B; Kamal M; Barua AR; Chowdhury MA; Mohsin AU; Ahmed S Bangladesh Med Res Counc Bull; 1997 Apr; 23(1):25-9. PubMed ID: 9363674 [TBL] [Abstract][Full Text] [Related]
28. Congenital megacalycosis with IgA nephropathy: a case report and review of the literature. Turkmen E; Yildirim T; Ciftci T; Altindal M; Akinci D; Baydar DE; Bilen CY; Arici M Ren Fail; 2013; 35(1):155-8. PubMed ID: 23252475 [TBL] [Abstract][Full Text] [Related]
29. Clinico-pathologic findings in medullary cystic kidney disease type 2. Bleyer AJ; Hart TC; Willingham MC; Iskandar SS; Gorry MC; Trachtman H Pediatr Nephrol; 2005 Jun; 20(6):824-7. PubMed ID: 15844001 [TBL] [Abstract][Full Text] [Related]
30. [A case of subclinical IgA nephropathy and cyclosporin associated arteriolopathy diagnosed by non-episode biopsy of graft kidney after renal transplantation]. Namba Y; Kyakuno M; Nakamura T; Yamashiro H; Okada M; Toki K; Ichimaru N; Kokado Y; Takahara S; Okuyama A; Oka K; Imai E; Kyo M Hinyokika Kiyo; 1999 May; 45(5):349-53. PubMed ID: 10410319 [TBL] [Abstract][Full Text] [Related]
31. Dabigatran-related Nephropathy Complicated by Tubulointerstitial Nephritis in a Patient with a Normal Renal Function and Undiagnosed IgA Nephropathy. Iwafuchi Y; Ito Y; Imai N; Oyama Y; Narita I Intern Med; 2024 Jun; 63(11):1615-1621. PubMed ID: 37866913 [TBL] [Abstract][Full Text] [Related]
32. Bronchiolitis obliterans and IgA nephropathy. A new cause of pulmonary-renal syndrome. Hernández JI; Gómez-Román J; Rodrigo E; Olmos JM; González-Vela C; Ruiz JC; Val JF; Riancho JA Am J Respir Crit Care Med; 1997 Aug; 156(2 Pt 1):665-8. PubMed ID: 9279256 [TBL] [Abstract][Full Text] [Related]
33. [Genetics and nosological classification of renal cystic diseases]. Izzi C; Sottini L; Dallera N; Capistrano M; Foini P; Scolari F G Ital Nefrol; 2010; 27 Suppl 50():S63-9. PubMed ID: 20922698 [TBL] [Abstract][Full Text] [Related]
34. [IgA nephropathy. Use of modern laboratory methods and renal biopsy for diagnosis]. Matousovic K; Martínek V Vnitr Lek; 2003 Nov; 49(11):869-73. PubMed ID: 14689683 [TBL] [Abstract][Full Text] [Related]
35. IgA nephropathy (IgAN) presenting with the nephrotic syndrome. Oviasu E Trop Geogr Med; 1992 Oct; 44(4):365-8. PubMed ID: 1295149 [TBL] [Abstract][Full Text] [Related]
36. [The incidence of renal diseases as diagnosed by biopsy in Hungary]. Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747 [TBL] [Abstract][Full Text] [Related]
38. Concurrence of de novo membranous glomerulonephritis and recurrent IgA nephropathy in a renal allograft. Pindur J; Mosheim MB; Giron MA; Guerriero WG; Suki W; Truong L Clin Nephrol; 1994 Oct; 42(4):269-72. PubMed ID: 7834922 [TBL] [Abstract][Full Text] [Related]
39. UMOD polymorphism rs12917707 is not associated with severe or stable IgA nephropathy in a large Caucasian cohort. Dinic M; Ghisdal L; Racapé J; Thibaudin L; Gatault P; Essig M; Le Meur Y; Noël C; Touchard G; Merville P; Ajarchouh Z; Mariat C; Abramowicz M; Abramowicz D; Alamartine E BMC Nephrol; 2014 Aug; 15():138. PubMed ID: 25163389 [TBL] [Abstract][Full Text] [Related]
40. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease. Komatsu H; Fujimoto S; Kikuchi M; Sato Y; Kitamura K Ren Fail; 2012; 34(4):448-53. PubMed ID: 22260382 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]